Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
NCT04881799Phase 1Active, not recruiting
- Sponsor
- University of Minnesota
- Start
- Jul 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and obesity comparing Placebo -> Qsymia with Qsymia -> Qsymia (2 arms). Primary endpoint: Body Mass Index at 6 months. Started Jul 2022; status: active, not recruiting.
02
Drugs
phentermine + topiramate
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT04881799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04881799.